Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Prostate Cancer
Drug:
Lutrate (leuprorelin depot)
(
GnRH agonist
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
New
Source:
FDA
Excerpt:
LUTRATE DEPOT is a gonadotropin-releasing hormone (GnRH) agonist indicated for:….Treatment of advanced prostate cancer.
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login